Treatment of Parkinson's disease with orphenadrine alone and in combination with L-dopa. - Suppr | 超能文献

Treatment of Parkinson's disease with orphenadrine alone and in combination with L-dopa.

作者信息

Bassi S, Albizzati M G, Calloni E, Sbacchi M, Frattola L

出版信息

Br J Clin Pract. 1986 Jul;40(7):273-5.

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Treatment of Parkinson's disease with orphenadrine alone and in combination with L-dopa.

Br J Clin Pract. 1986 Jul;40(7):273-5.

2

Combined treatment in Parkinson's disease.帕金森病的联合治疗

Practitioner. 1983 Mar;227(1377):446-7.

3

L-dopa and (-)-deprenil in the treatment of Parkinson's disease: a long-term study [proceedings].左旋多巴与（-）-司来吉兰治疗帕金森病：一项长期研究[会议论文集]

Br J Pharmacol. 1976 Nov;58(3):423P-424P.

4

[CB 154 in the treatment of parkinson's disease--results of the association with L-DOPA + DDI (author's transl)].CB 154治疗帕金森病——与左旋多巴+脱羧酶抑制剂联合应用的结果（作者译）

Schweiz Rundsch Med Prax. 1976 May 4;65(18):557-9.

5

Treatment strategies in Parkinson's disease after a quarter century experiences with L-DOPA therapy.在经历四分之一个世纪的左旋多巴治疗后帕金森病的治疗策略。

J Neural Transm Suppl. 1995;46:381-9.

6

[Improved therapeutic response to L-dopa in Parkinson's disease, when combined with bromocriptine (author's transl)].

Nervenarzt. 1981 Feb;52(2):116-20.

7

Mental impairment in Parkinson's disease. The role of anticholinergic drugs.帕金森病中的精神障碍。抗胆碱能药物的作用。

Acta Psychiatr Belg. 1984 Jul-Aug;84(4):325-35.

8

Low-dosage treatment in de novo patients with Parkinson's disease: a prospective study.帕金森病初发患者的低剂量治疗：一项前瞻性研究。

Adv Neurol. 1987;45:529-34.

9

[The L-dopa test in Parkinson's disease].[帕金森病的左旋多巴试验]

Rev Neurol (Paris). 1985;141(5):413-5.

10

[A new levodopa benserazide preparation for Parkinson's disease with motor fluctuations refractory to standard L-dopa].[一种用于治疗对标准左旋多巴治疗反应不佳且伴有运动波动的帕金森病的新型左旋多巴苄丝肼制剂]

Medicina (B Aires). 1991;51(6):561-7.

引用本文的文献

1

deepDR: a network-based deep learning approach to in silico drug repositioning.深度重定位（deepDR）：一种基于网络的深度学习方法，用于计算机药物重定位。

Bioinformatics. 2019 Dec 15;35(24):5191-5198. doi: 10.1093/bioinformatics/btz418.

2

Orphenadrine is an uncompetitive N-methyl-D-aspartate (NMDA) receptor antagonist: binding and patch clamp studies.奥芬那君是一种非竞争性N-甲基-D-天冬氨酸（NMDA）受体拮抗剂：结合与膜片钳研究。

J Neural Transm Gen Sect. 1995;102(3):237-46. doi: 10.1007/BF01281158.